Bruntwood SciTech said it is launching a new Life Science Accelerator programme at Alderley Park to help biotech companies bring their ideas to fruition and into the market.

Alderley Park, near Macclesfield and Alderley Edge, is a science park housing more than 250 technology companies with some shared infrastructure. It is owned and operated by Bruntwood SciTech, a joint venture between Bruntwood, finance giant Legal & General and Greater Manchester Pension Fund.

Bruntwood said the Life Science Accelerator will cater to early-stage life science companies across the UK. Successful applicants will receive personalised support aimed at accelerating their idea from lab through to commercialisation. 

The six-month programme will combine specialist laboratory incubation support and business model development, with expertise provided by industry leaders from Bruntwood SciTech partners including Triple Chasm, ThermoFisher Scientific, Marks & Clerk, Pharmalytical Services, Mercia Ventures and Praetura Group. The programme will be limited to 10 early-stage life science venture companies. Each recipient will receive support valued at about £60,000.

The project is being funded by the UK Government through the UK Shared Prosperity Fund, which has committed £2.6 billion to local investment by March 2025 and is part of the UK government’s Levelling Up agenda. 

Dr Kath Mackay, Chief Scientific Officer at Bruntwood SciTech, said: “The new Life Science Accelerator programme truly embodies our dedication to supporting early-stage life science companies across the UK by providing them with the necessary resources and guidance to thrive. Our mission is to empower these companies to bring their innovative ideas to fruition, ultimately contributing to the advancement of the life sciences sector and the broader economy.”